Atlas Trials

The Effect of Roxadustat on Renal Oxygenation in Diabetes Nephropathy

Clinical trial NCT05810311 · NOT_YET_RECRUITING

Trial details

NCT number
NCT05810311
Sponsor
Region Stockholm
Status
NOT_YET_RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Diabetes ComplicationsDiabetes; Nephropathy (Manifestation)
Start date
2025-06-01
Primary completion
2027-01-01
Enrollment
30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.